Insulin-like growth factor-I is essential for embryonic bone development.

Area of Science:

• Skeletal Biology
• Developmental Biology
• Endocrinology

Background:

• Insulin-like growth factor I (IGF-I) is a known regulator of skeletal growth.
• The specific role of IGF-I during embryonic skeletal development is not well understood.

Purpose of the Study:

• To investigate the function of IGF-I in embryonic skeletal development.
• To elucidate the cellular and molecular mechanisms by which IGF-I influences bone formation.

Main Methods:

• Analysis of IGF-I-deficient (IGF-I(-/-)) mice from embryonic day 14.5 to 18.5.
• Histological examination of skeletal elements, including spinal column, sternum, and long bones.
• Assessment of chondrocyte proliferation, apoptosis, differentiation, and mineralization markers.
• Evaluation of gene expression related to skeletal development, including Indian hedgehog and PTHrP.

Main Results:

• IGF-I(-/-) mice exhibited short-limbed dwarfism and delayed mineralization in multiple skeletal elements.
• Reduced chondrocyte proliferation and increased apoptosis were observed in the spinal ossification center and growth plates.
• Abnormal chondrocyte differentiation, characterized by fewer hypertrophic chondrocytes and lower osteocalcin expression, was noted.
• The Indian hedgehog-PTHrP signaling pathway was dysregulated, with decreased Indian hedgehog and increased PTHrP expression.

Conclusions:

• IGF-I is essential for normal embryonic skeletal development.
• IGF-I promotes chondrocyte proliferation and maturation while inhibiting apoptosis.
• IGF-I signaling is critical for establishing appropriate bone size and strength through regulation of chondrogenesis and mineralization.